These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10961443)

  • 1. Oral Cerebrolysin enhances brain alpha activity and improves cognitive performance in elderly control subjects.
    Alvarez XA; Lombardi VR; Corzo L; Pérez P; Pichel V; Laredo M; Hernández A; Freixeiro F; Sampedro C; Lorenzo R; Alcaraz M; Windisch M; Cacabelos R
    J Neural Transm Suppl; 2000; 59():315-28. PubMed ID: 10961443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide dietary supplement N-PEP-12 enhances cognitive function and activates brain bioelectrical activity in healthy elderly subjects.
    Alvarez XA; Corzo L; Laredo M; Sampedro C; Cacabelos R; Windisch M; Moessler H; Crook TH
    Methods Find Exp Clin Pharmacol; 2005 Sep; 27(7):483-7. PubMed ID: 16258593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-dependent effects of Cerebrolysin on EEG and short-term memory of healthy volunteers during control and hyperventilation induced cerebral ischemia.
    Funke M; Fiehler J; Mewes I; Eiselt M; Rother I; Windisch M
    J Neural Transm Suppl; 1998; 53():385-98. PubMed ID: 9700674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot study to evaluate the effects of Cerebrolysin on cognition and qEEG in vascular dementia: cognitive improvement correlates with qEEG acceleration.
    Muresanu DF; Alvarez XA; Moessler H; Buia M; Stan A; Pintea D; Moldovan F; Popescu BO
    J Neurol Sci; 2008 Apr; 267(1-2):112-9. PubMed ID: 18048059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion.
    Alvarez XA; Mouzo R; Pichel V; Pérez P; Laredo M; Fernández-Novoa L; Corzo L; Zas R; Alcaraz M; Secades JJ; Lozano R; Cacabelos R
    Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):633-44. PubMed ID: 10669911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive effects of cerebrolysin on electroencephalogram slowing, cognition and clinical outcome in patients with postacute traumatic brain injury: an exploratory study.
    Alvarez XA; Sampedro C; Pérez P; Laredo M; Couceiro V; Hernández A; Figueroa J; Varela M; Arias D; Corzo L; Zas R; Lombardi V; Fernández-Novoa L; Pichel V; Cacabelos R; Windisch M; Aleixandre M; Moessler H
    Int Clin Psychopharmacol; 2003 Sep; 18(5):271-8. PubMed ID: 12920387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of the effects of Cerebrolysin on cognition and qEEG slowing in vascular dementia patients: results of a 3-month extension study.
    Muresanu DF; Alvarez XA; Moessler H; Novak PH; Stan A; Buzoianu A; Bajenaru O; Popescu BO
    J Neurol Sci; 2010 Dec; 299(1-2):179-83. PubMed ID: 20923712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological effects and brain protection by hypothermia and cerebrolysin after moderate forebrain ischemia in rats.
    Schwab M; Bauer R; Zwiener U
    Exp Toxicol Pathol; 1997 Feb; 49(1-2):105-16. PubMed ID: 9085084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of TC-1734 (AZD3480), a selective neuronal nicotinic receptor agonist, on cognitive performance and the EEG of young healthy male volunteers.
    Dunbar G; Boeijinga PH; Demazières A; Cisterni C; Kuchibhatla R; Wesnes K; Luthringer R
    Psychopharmacology (Berl); 2007 May; 191(4):919-29. PubMed ID: 17225162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrolysin in vascular dementia: improvement of clinical outcome in a randomized, double-blind, placebo-controlled multicenter trial.
    Guekht AB; Moessler H; Novak PH; Gusev EI;
    J Stroke Cerebrovasc Dis; 2011; 20(4):310-8. PubMed ID: 20656516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrolysin enhances the expression of the synaptogenic protein LRRTM4 in the hippocampus and improves learning and memory in senescent rats.
    Flores-Páez LA; Pacheco-Rosado J; Alva-Sánchez C; Zamudio SR
    Behav Pharmacol; 2020 Aug; 31(5):491-499. PubMed ID: 31850962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of the nootropic agent cerebrolysin in cerebral ischemia in rats with varying behavioral reactions in the open field test].
    Gannushkina IV; Antelava AL; Baranchikova MV
    Patol Fiziol Eksp Ter; 1998; (2):3-8. PubMed ID: 9633187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphofunctional effects of moderate forebrain ischemia combined with short-term hypoxia in rats--protective effects of Cerebrolysin.
    Schwab M; Schaller R; Bauer R; Zwiener U
    Exp Toxicol Pathol; 1997 Feb; 49(1-2):29-37. PubMed ID: 9085071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Electrophysiological correlates of efficacy of nootropic drugs in the treatment of consequences of traumatic brain injury in adolescents].
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(5 Suppl 1):27-32. PubMed ID: 20559264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The drug cerebrolysin and its peptide fraction E021 increase the abundance of the blood-brain barrier GLUT1 glucose transporter in brains of young and old rats.
    Gschanes A; Boado R; Sametz W; Windisch M
    Histochem J; 2000 Feb; 32(2):71-7. PubMed ID: 10816070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Short-term effects of septo-hippocampal pathway transsection and cerebrolysin effects on glutathione-related enzymes in the rat brain].
    Cruz R; Francis L; Díaz-Suárez CM; González-Fraguela ME
    Rev Neurol; 1998 Apr; 26(152):551-4. PubMed ID: 9796003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind, placebo-controlled, multicenter study of Cerebrolysin for Alzheimer's disease.
    Bae CY; Cho CY; Cho K; Hoon Oh B; Choi KG; Lee HS; Jung SP; Kim DH; Lee S; Choi GD; Cho H; Lee H
    J Am Geriatr Soc; 2000 Dec; 48(12):1566-71. PubMed ID: 11129744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrolysin ameliorates performance deficits, and neuronal damage in apolipoprotein E-deficient mice.
    Masliah E; Armasolo F; Veinbergs I; Mallory M; Samuel W
    Pharmacol Biochem Behav; 1999 Feb; 62(2):239-45. PubMed ID: 9972690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind, randomized, placebo-controlled pilot study with anapsos in senile dementia: effects on cognition, brain bioelectrical activity and cerebral hemodynamics.
    Alvarez XA; Pichel V; Pérez P; Laredo M; Corzo D; Zas R; Fernández-Novoa L; Sempere JM; Díaz J; Cacabelos R
    Methods Find Exp Clin Pharmacol; 2000 Sep; 22(7):585-94. PubMed ID: 11196347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrolysin enhances cognitive recovery of mild traumatic brain injury patients: double-blind, placebo-controlled, randomized study.
    Chen CC; Wei ST; Tsaia SC; Chen XX; Cho DY
    Br J Neurosurg; 2013 Dec; 27(6):803-7. PubMed ID: 23656173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.